Citadel Advisors’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
VCM
GKFF
GS
RHJA
Citadel Advisors's ASPN Position: Q1 2026 in Review
Citadel Advisors reduced its Aspen Aerogels (ASPN) stake by 33% in Q1 2026, selling an estimated $961K and leaving 581,187 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6076.
Citadel Advisors first reported a position in ASPN in Q4 2015 and has held it in 25 quarters since. The position peaked at $15M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.
- Citadel Advisors held 581,187 shares of Aspen Aerogels worth $1.99M as of Q1 2026.
- Citadel Advisors sold 285,031 Aspen Aerogels shares in Q1 2026, an estimated $961K.
- Aspen Aerogels made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6076 holding.
- Citadel Advisors first reported a position in Aspen Aerogels in Q4 2015 and has held it in 25 quarters since.
- Citadel Advisors's Aspen Aerogels position peaked at $15M in Q2 2024.
- 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.